Drawing for EFFIPURE

USPTO serial 78246742

EFFIPURE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
ANKRAH, NAAKWAMA S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EFFIPURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Douglas R. Wolf

DOUGLAS R WOLF WOLF, GREENFIELD & SACKS PC600 ATLANTIC AVEBOSTON, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Gel cassettes with and without a base, safety cover, comb, electrode and power supply for scientific or medical research use; Microarray apparatus with and without slides, optical scanner and software for scientific or medical research use; Apparatus, namely microarrays for scientific or medical research use; Apparatus for scientific or medical research, namely gel cassettes for use in electrophoresis assays; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in detecting analytes; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in purifying analytes; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in separating analytes; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in detecting nucleic acid sequences; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in purifying nucleic acid sequences; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in separating nucleic acid sequences; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in detecting contamination in blood products; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in detecting bacterial contamination in blood products; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in detecting viral contamination in blood products; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in detecting contamination in platelet products; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for use in detecting bacterial contamination in platelet products; Apparatus for scientific or medical research use in electrophoresis assays, namely gel cassettes for identifying bacterial pathogens; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect analytes; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to purify analytes; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to separate analytes; Apparatus kits for scientific or medical research use, namely kits comprised of gel cassettes and reagents used to detect nucleic acid sequences; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to purify nucleic acid sequences; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to separate nucleic acid sequences; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect contamination in blood products; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect bacterial contamination in blood products; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect viral contamination in blood products; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect contamination in platelet products; Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect bacterial contamination in platelet products; and Apparatus kits for scientific or medical research use in electrophoresis assays, namely kits comprised of gel cassettes and reagents used to identify bacterial pathogensACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 13, 2005MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 13, 2005ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 17, 2005ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 17, 2005REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 5, 2005EX1GSOU EXTENSION 1 GRANTED—
Mar 30, 2005EXT1SOU EXTENSION 1 FILED—
Mar 30, 2005FAXXFAX RECEIVED—
Oct 12, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 20, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2004NPUBNOTICE OF PUBLICATION—
May 3, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2004MAILPAPER RECEIVED—
Nov 17, 2003UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Nov 17, 2003MAILPAPER RECEIVED—
Oct 8, 2003GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 6, 2003DOCKASSIGNED TO EXAMINER—
Aug 6, 2003MAILPAPER RECEIVED—

Frequently asked questions

Related guidance